News

Antibody-mediated protection mechanism expands tuberculosis treatment options
Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...
TMCnet16h
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
ascopubs.org21h
Dose escalation and expansion from the phase I study of DS-1062, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), in patients (pts) with advanced non ...
FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full ...